The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Chromium Picolinate Supplementation Attenuates Body Weight Gain and Increases Insulin Sensitivity in Subjects With Type 2 Diabetes
Open accessAbstract
OBJECTIVE—Chromium picolinate (CrPic) supplementation has been suggested to improve glycemia, but there are conflicting reports on efficacy. We sought to determine the effect of CrPic on insulin sensitivity, glycemic control, and body composition in subjects with type 2 diabetes. RESEARCH DESIGN AND METHODS—Thirty-seven subjects with type 2 diabetes were evaluated. After baseline, subjects were placed on a sulfonylurea (glipizide gastrointestinal therapeutic system 5 mg/day) with placebo for 3 months. Subjects were then randomized in a double-blind fashion to receive either the sulfonylurea plus placebo (n = 12) or the sulfonylurea plus 1,000 μg Cr as CrPic (n = 17) for 6 months. Body composition, insulin sensitivity, and glycemic control were determined at baseline, end of the 3-month single-blind placebo phase, and end of study. RESULTS—Subjects randomized to sulfonylurea/placebo, as opposed to those randomized to sulfonylurea/CrPic, had a significant increase in body weight (2.2 kg, P < 0.001 vs. 0.9 kg, P = 0.11), percent body fat (1.17%, P < 0.001 vs. 0.12%, P = 0.7), and total abdominal fat (32.5 cm2, P < 0.05 vs. 12.2 cm2, P < 0.10) from baseline. Subjects randomized to sulfonylurea/CrPic had significant improvements in insulin sensitivity corrected for fat-free mass (28.8, P < 0.05 vs. 15.9, P = 0.4), GHb (−1.16%, P < 0.005 vs. −0.4%, P = 0.3), and free fatty acids (−0.2 mmol/l, P < 0.001 vs. −0.12 mmol/l, P < 0.03) as opposed to sulfonylurea/placebo. CONCLUSIONS—This study demonstrates that CrPic supplementation in subjects with type 2 diabetes who are taking sulfonylurea agents significantly improves insulin sensitivity and glucose control. Further, CrPic supplementation significantly attenuated body weight gain and visceral fat accumulation compared with the placebo group.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chromium intake, absorption and excretion of subjects consuming self-selected diets
Anderson, R., & Kozlovsky, A. (1985) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/41.6.1177 · Cited by 369
Lukaski, H., Bolonchuk, W., Siders, W., & Milne, D. (1996) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/63.6.954 · Cited by 164
Clancy, S. P., Clarkson, P. M., DeCheke, M. E., Nosaka, K., Freedson, P. S., Cunningham, J. J., & Valentine, B. (1994) · International Journal of Sport Nutrition · doi:10.1123/ijsn.4.2.142 · Cited by 118
Cefalu, W. T., Wang, Z. Q., Bell-Farrow, A., Kiger, F. D., & Izlar, C. (1994) · Clinical Chemistry · doi:10.1093/clinchem/40.7.1317 · Cited by 92
Self-citationKaats, G. R., Blum, K., Fisher, J. A., & Adelman, J. A. (1996) · Current Therapeutic Research · doi:10.1016/s0011-393x(96)80080-4 · Cited by 79
Campbell, W. W., Joseph, L. J. O., Anderson, R. A., Davey, S. L., Hinton, J., & Evans, W. J. (2002) · International Journal of Sport Nutrition and Exercise Metabolism · doi:10.1123/ijsnem.12.2.125 · Cited by 46
Cited by
Loladze, I. (2014) · eLife · doi:10.7554/elife.02245 · Cited by 502
Effect of Chromium Supplementation on Glucose Metabolism and Lipids
Balk, E. M., Tatsioni, A., Lichtenstein, A. H., Lau, J., & Pittas, A. G. (2007) · Diabetes Care · doi:10.2337/dc06-0996 · Cited by 294
Treatments for women with gestational diabetes mellitus: an overview of Cochrane systematic reviews
Martis, R., Crowther, C. A., Shepherd, E., Alsweiler, J., Downie, M. R., & Brown, J. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012327.pub2 · Cited by 159
Suksomboon, N., Poolsup, N., & Yuwanakorn, A. (2014) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.12147 · Cited by 154
Liu, Y., Cotillard, A., Vatier, C., Bastard, J.-P., Fellahi, S., Stévant, M., Allatif, O., Langlois, C., Bieuvelet, S., Brochot, A., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0138646 · Cited by 71
Metadata
- Authors
- Martin, J., Wang, Z. Q., Zhang, X. H., Wachtel, D., Volaufova, J., Matthews, D. E., & Cefalu, W. T.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2006-08-01
- Volume
- 29
- Issue
- 8
- Pages
- 1826-1832
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2156828019
- Cited by
- 207
- References
- 6
- FWCI
- 15.60
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Chromium Picolinate Supplementation Attenuates Body Weight Gain and Increases Insulin Sensitivity in Subjects With Type 2 Diabetes. https://app.cochat.ai/papers/10.2337/dc06-0254
- The paper
- Martin, J., Wang, Z. Q., Zhang, X. H., Wachtel, D., Volaufova, J., Matthews, D. E., & Cefalu, W. T. (2006). Chromium Picolinate Supplementation Attenuates Body Weight Gain and Increases Insulin Sensitivity in Subjects With Type 2 Diabetes. Diabetes Care. https://doi.org/10.2337/dc06-0254
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.